 Home > Active Ingredient News > Antitumor Therapy > Lancet oncol: The quality of life of patients with colon cancer who receive care led by different doctors after surgery

Lancet oncol: The quality of life of patients with colon cancer who receive care led by different doctors after surgery

 Last Update: 2021-08-02
 Source: Internet
 Author: User

Tags

time care

trehalose skin care

Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

Colon cancer is associated with an increased risk of physical and psychosocial disease, even after treatment

Colon cancerColorectal cancer

Researchers conducted a pragmatic 2×2 factorial, open-label, randomized, controlled trial in eight hospitals in the Netherlands, and included patients with stage I-III colon cancer or rectal and sigmoid cancer undergoing radical surgery.

From March 26, 2015 to November 21, 2018, a total of 353 patients were recruited

QOL changes for each group

The median follow-up was 12.

At 2 months, there was no clinically significant difference in QOL changes between the surgeon-led care group and the GP-led care group; there was no significant difference between the Oncokompas group and the non-Oncokompas group

In terms of QOL, in the first year after colon cancer treatment, GP-led survival care may replace surgeon-led care

Original source:

Julien AM Vos, et al.

Effect of general practitioner-led versus surgeon-led colon cancer survivorship care, with or without eHealth support, on quality of life (I CARE): an interim analysis of 1-year results of a randomised, controlled trial.

Leave a message here

This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

Related Products

Gefitinib

CAS No.: 184475-35-2

Pharmacy Grade

$1/MT FOB

High quality Sunitinib CAS NO 557795-19-4 Orange solid powder 99% API for antitumor

CAS No.: 557795-19-4

Pharmacy Grade

$4.1-4.2/G FOB

Epirubicin

CAS No.: 56420-45-2

$1/KG EXW

Hot Tags

united states jobs(223)

jobs united states(236)

1 year treasury(277)

1 year subscription(296)

announcements today(81)

80 20 company(94)

united states logo(227)

single use technology(195)

healthy food name(42)

ups united states(221)

Hot Articles

The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.